Gabapentin enacarbil for restless legs syndrome (PIVOT RLS II trial)
www.pulmccm.org
Lee et al report phase III trial results for this prodrug of gabapentin. It improved symptoms in people with moderate-to-severe RLS at the end of 12 weeks, compared to placebo. However, time (placebo) also worked well. The FDA approved the drug for moderate-to-severe RLS in April 2011.
Gabapentin enacarbil for restless legs syndrome (PIVOT RLS II trial)
Gabapentin enacarbil for restless legs…
Gabapentin enacarbil for restless legs syndrome (PIVOT RLS II trial)
Lee et al report phase III trial results for this prodrug of gabapentin. It improved symptoms in people with moderate-to-severe RLS at the end of 12 weeks, compared to placebo. However, time (placebo) also worked well. The FDA approved the drug for moderate-to-severe RLS in April 2011.